VivoSeq
Other

Single Dose

0

Pipeline Programs↗

22

Active Trials↗

135

Companies Involved↗

Single Dose is an early-stage landscape with 0 programs across 135 companies. The most active players are Pfizer, GSK, AstraZeneca.

Intelligence

Pipeline Metrics

Competitive Density

37/100

Pipeline Velocity

27/100

Mech. Concentration

N/A

Completion Rate

94/100

Attrition Rate

5/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalBayer logo

Bayer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

609

clinical trials

Completed541 · 89%
Terminated26 · 4%
Unknown status13 · 2%
Recruiting11 · 2%
Withdrawn7 · 1%
Active, not recruiting6 · 1%
Other5 · 1%

Clinical Trials

Trial Activity

609 trials

Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants
Recruiting·BioMarin Pharmaceutical logoBioMarin Pharmaceutical·Phase 1·NCT06738017·12 enrolled
Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
Recruiting·EEnsysce Biosciences·Phase 1·NCT06500793·30 enrolled
A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants
Recruiting·SSynendos Therapeutics AG·Phase 1·NCT06670950·90 enrolled
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults
Recruiting·UUniversity of California, Berkeley·Phase 1·NCT06367738·40 enrolled
A Phase I Clinical Study of a Single Dose of KLA480
Recruiting·SSichuan Kelun Pharmaceutical Research Institute Co., Ltd.·Phase 1·NCT07030790·20 enrolled
Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia
Recruiting·MMakerere University·Phase 2/3·NCT03945448·356 enrolled
Single Dose Escalation Study of CM383 in Healthy Volunteers
Recruiting·KKeymed Biosciences Co.Ltd·Phase 1·NCT06412185·56 enrolled
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.
Recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd logoGuangdong Hengrui Pharmaceutical Co., Ltd·Phase 1·NCT07116915·160 enrolled
Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
Recruiting·AAddpharma Inc.·Phase 1·NCT07385235·46 enrolled
Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.
Recruiting·HHC Biopharma Inc.·Phase 1·NCT06657703·38 enrolled
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
Recruiting·DDrugs for Neglected Diseases·Phase 2/3·NCT05433350·35 enrolled
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
Active, not recruiting·BBiomica Ltd.·Phase 1·NCT05354102·11 enrolled
Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
Active, not recruiting·—·Phase 2·NCT05418049·45 enrolled
To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers
Active, not recruiting·HHK inno.N Corporation·Phase 1·NCT06725355·60 enrolled
The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol
Active, not recruiting·MMcMaster University·Phase 1·NCT05742724·24 enrolled
Page 1 of 41

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)